Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regenxbio (RGNX) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Regenxbio (RGNX) over the last 12 years, with Q3 2025 value amounting to $4.3 million.

  • Regenxbio's Other Non-Current Assets rose 11024.63% to $4.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.3 million, marking a year-over-year increase of 11024.63%. This contributed to the annual value of $4.0 million for FY2024, which is 1678.8% down from last year.
  • Per Regenxbio's latest filing, its Other Non-Current Assets stood at $4.3 million for Q3 2025, which was up 11024.63% from $2.0 million recorded in Q2 2025.
  • In the past 5 years, Regenxbio's Other Non-Current Assets registered a high of $4.8 million during Q4 2023, and its lowest value of $1.3 million during Q1 2021.
  • Over the past 5 years, Regenxbio's median Other Non-Current Assets value was $2.0 million (recorded in 2021), while the average stood at $2.4 million.
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first skyrocketed by 13679.8% in 2023, then plummeted by 1678.8% in 2024.
  • Over the past 5 years, Regenxbio's Other Non-Current Assets (Quarter) stood at $2.0 million in 2021, then changed by 0.0% to $2.0 million in 2022, then soared by 136.8% to $4.8 million in 2023, then decreased by 16.79% to $4.0 million in 2024, then grew by 6.7% to $4.3 million in 2025.
  • Its Other Non-Current Assets was $4.3 million in Q3 2025, compared to $2.0 million in Q2 2025 and $3.0 million in Q1 2025.